Mariner
MEDP icon

Mariner’s Medpace MEDP Stock Holding History

Mariner’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Sell
31,638
-8,339
-21% -$3.85M 0.02% 528
2026
Q1 		$19.2M Buy
39,977
+2,197
+6% +$1.12M 0.02% 481
2025
Q4 		$21.2M Buy
37,780
+22,942
+155% +$13M 0.03% 431
2025
Q3 		$7.63M Buy
14,838
+8,808
+146% +$3.85M 0.01% 739
2025
Q2 		$1.89M Buy
6,030
+1,568
+35% +$471K ﹤0.01% 1370
2025
Q1 		$1.36M Buy
4,462
+1,637
+58% +$551K ﹤0.01% 1477
2024
Q4 		$939K Buy
2,825
+840
+42% +$285K ﹤0.01% 1707
2024
Q3 		$662K Buy
1,985
+275
+16% +$104K ﹤0.01% 1918
2024
Q2 		$704K Buy
1,710
+513
+43% +$203K ﹤0.01% 1769
2024
Q1 		$484K Sell
1,197
-799
-40% -$281K ﹤0.01% 2045
2023
Q4 		$612K Buy
1,996
+600
+43% +$162K ﹤0.01% 1807
2023
Q3 		$338K Sell
1,396
-118
-8% -$30.2K ﹤0.01% 2056
2023
Q2 		$364K Buy
1,514
+3
+0.2% +$623 ﹤0.01% 1974
2023
Q1 		$284K Sell
1,511
-431
-22% -$89.1K ﹤0.01% 2117
2022
Q4 		$413K Buy
1,942
+324
+20% +$64.7K ﹤0.01% 1778
2022
Q3 		$254K Buy
+1,618
New +$258K ﹤0.01% 1890

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Mariner's MEDP Position: Q2 2026 in Review

Mariner reduced its Medpace (MEDP) stake by 21% in Q2 2026, selling an estimated $3.85M and leaving 31,638 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #528.

Mariner first reported a position in MEDP in Q3 2022 and has held it in 16 quarters since. The position peaked at $21.2M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mariner held 31,638 shares of Medpace worth $16.8M as of Q2 2026.
  • Mariner sold 8,339 Medpace shares in Q2 2026, an estimated $3.85M.
  • Medpace made up 0.02% of Mariner's portfolio in Q2 2026, its #528 holding.
  • Mariner first reported a position in Medpace in Q3 2022 and has held it in 16 quarters since.
  • Mariner's Medpace position peaked at $21.2M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.